Ngā hua rapu - Camilla Cervin
- E whakaatu ana i te 1 - 4 hua o te 4
-
1
Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF‐1 suppression to octreotide LAR in healthy volunteers mā Fredrik Tiberg, John G. Roberts, Camilla Cervin, Markus Johnsson, Séverine Sarp, Anadya Prakash Tripathi, Margareta Linden
I whakaputaina 2015Artigo -
2
-
3
Impaired Mitochondrial Function and Insulin Resistance of Skeletal Muscle in Mitochondrial Diabetes mā Julia Szendroedi, A. Schmid, Martin Meyerspeer, Camilla Cervin, Michaela Kacerovsky, Gerhard Smekal, Sabine Gräser-Lang, Leif Groop, Michael Roden
I whakaputaina 2009Artigo -
4
Association of Common Variation in the <i>HNF1α</i> Gene Region With Risk of Type 2 Diabetes mā Wendy Winckler, Noël P. Burtt, Johan Holmkvist, Camilla Cervin, Paul I.W. de Bakker, Maria Sun, Peter Almgren, Jaakko Tuomilehto, Daniel Gaudet, Thomas J. Hudson, Kristin Ardlie, Mark J. Daly, Joel N. Hirschhorn, David Altshuler, Leif Groop
I whakaputaina 2005Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Endocrinology
Medicine
Biology
Diabetes mellitus
Gene
Internal medicine
Type 2 diabetes
Genetics
Genotype
Single-nucleotide polymorphism
Adverse effect
Allele
Antigen
Archaeology
Association (psychology)
Astrophysics
Bioavailability
Biochemistry
Computational biology
Depot
Genetic association
History
Human leukocyte antigen
Immunology
Insulin
Insulin resistance
Lactic acidosis
MELAS syndrome
Mitochondrial DNA
Mitochondrial myopathy